Moneycontrol
Last Updated : Jan 10, 2018 04:59 PM IST | Source: Moneycontrol.com

Alkem Laboratories gains 3% on EIR for Baddi plant

The said plant was inspected from September 11, 2017 to September 15, 2017.

Shares of Alkem Laboratories ended with a gain of 3.5 percent as the USFDA issued EIR for the company's Baddi plant.

The US Food and Drug Administration (USFDA) has issued an establishment inspection report (EIR) for the company's manufacturing facility located at Baddi, India.

The said plant was inspected from September 11, 2017 to September 15, 2017.

In response to the two Form 483 observations issued by the USFDA, the company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines.

The inspection has now been closed by the USFDA.

Alkem Laboratories ended at Rs 2,297, up Rs 76.70, or 3.45 percent. It has touched a 52-week high of Rs 2,468.

Posted by Rakesh Patil
First Published on Jan 10, 2018 03:38 pm
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant